1. Home
  2. WETH vs INTS Comparison

WETH vs INTS Comparison

Compare WETH & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.92

Market Cap

21.1M

Sector

N/A

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$5.23

Market Cap

19.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
INTS
Founded
1992
2012
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1M
19.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
WETH
INTS
Price
$1.92
$5.23
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
57.4K
22.4K
Earning Date
04-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
15.38
N/A
EPS
0.60
N/A
Revenue
$45,136,818.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.08
N/A
Revenue Growth
6.76
N/A
52 Week Low
$0.78
$0.19
52 Week High
$3.68
$8.06

Technical Indicators

Market Signals
Indicator
WETH
INTS
Relative Strength Index (RSI) 72.20 43.31
Support Level $1.82 $5.08
Resistance Level $2.06 $8.06
Average True Range (ATR) 0.14 0.28
MACD 0.06 -0.05
Stochastic Oscillator 90.14 30.16

Price Performance

Historical Comparison
WETH
INTS

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: